title: Relationship between malaria incidence and IgG levels to Plasmodium falciparum merozoite antigens in Malian children: impact of hemoglobins S and C.
abstract: Heterozygous hemoglobin (Hb) AS (sickle-cell trait) and HbAC are hypothesized to protect against Plasmodium falciparum malaria in part by enhancing naturally-acquired immunity to this disease. To investigate this hypothesis, we compared antibody levels to four merozoite antigens from the P. falciparum 3D7 clone (apical membrane antigen 1, AMA1-3D7; merozoite surface protein 1, MSP1-3D7; 175 kDa erythrocyte-binding antigen, EBA175-3D7; and merozoite surface protein 2, MSP2-3D7) in a cohort of 103 HbAA, 73 HbAS and 30 HbAC children aged 3 to 11 years in a malaria-endemic area of Mali. In the 2009 transmission season we found that HbAS, but not HbAC, significantly reduced the risk of malaria compared to HbAA. IgG levels to MSP1 and MSP2 at the start of this transmission season inversely correlated with malaria incidence after adjusting for age and Hb type. However, HbAS children had significantly lower IgG levels to EBA175 and MSP2 compared to HbAA children. On the other hand, HbAC children had similar IgG levels to all four antigens. The parasite growth-inhibitory activity of purified IgG samples did not differ significantly by Hb type. Changes in antigen-specific IgG levels during the 2009 transmission and 2010 dry seasons also did not differ by Hb type, and none of these IgG levels dropped significantly during the dry season. These data suggest that sickle-cell trait does not reduce the risk of malaria by enhancing the acquisition of IgG responses to merozoite antigens.
authors.affiliation: Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA. kmiura@niaid.nih.gov
authors.forename: Kazutoyo
authors.initials: K
authors.lastname: Miura
authors.forename: Mahamadou
authors.initials: M
authors.lastname: Diakite
authors.forename: Ababacar
authors.initials: A
authors.lastname: Diouf
authors.forename: Saibou
authors.initials: S
authors.lastname: Doumbia
authors.forename: Drissa
authors.initials: D
authors.lastname: Konate
authors.forename: Abdoul S
authors.initials: AS
authors.lastname: Keita
authors.forename: Samuel E
authors.initials: SE
authors.lastname: Moretz
authors.forename: Gregory
authors.initials: G
authors.lastname: Tullo
authors.forename: Hong
authors.initials: H
authors.lastname: Zhou
authors.forename: Tatiana M
authors.initials: TM
authors.lastname: Lopera-Mesa
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Anderson
authors.forename: Rick M
authors.initials: RM
authors.lastname: Fairhurst
authors.forename: Carole A
authors.initials: CA
authors.lastname: Long
mesh_terms: D000293:Adolescent; D000953:Antigens, Protozoan / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006444:Hemoglobin C / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D015994:Incidence; D007223:Infant; D016778:Malaria, Falciparum / Q000453:epidemiology* / Q000276:immunology*; D008297:Male; D052940:Merozoites / Q000276:immunology*; D010963:Plasmodium falciparum / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity*
chemical_list: D000953:Antigens, Protozoan; D006451:Hemoglobin, Sickle; D007074:Immunoglobulin G; D006444:Hemoglobin C
references.citation: PLoS One. 2011;6(9):e24413
references.pmid: 21949716
references.citation: Parasite Immunol. 1993 Sep;15(9):513-24
references.pmid: 7877849
references.citation: Gene. 2010 Nov 1;467(1-2):1-12
references.pmid: 20655368
references.citation: J Infect Dis. 2003 Mar 1;187(5):862-5
references.pmid: 12599061
references.citation: Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
references.pmid: 11103309
references.citation: Blood. 2010 Jun 3;115(22):4551-8
references.pmid: 20231425
references.citation: Clin Infect Dis. 1999 Apr;28(4):794-9
references.pmid: 10825041
references.citation: Immunol Lett. 2002 Oct 21;84(1):9-16
references.pmid: 12161278
references.citation: Infect Immun. 2008 Apr;76(4):1748-55
references.pmid: 18212081
references.citation: Infect Immun. 2005 Jun;73(6):3677-85
references.pmid: 15908397
references.citation: PLoS Clin Trials. 2007;2(4):e12
references.pmid: 17415408
references.citation: PLoS One. 2007 Oct 03;2(10):e978
references.pmid: 17912355
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):991-6
references.pmid: 18192399
references.citation: J Infect Dis. 2005 May 15;191(10):1631-8
references.pmid: 15838789
references.citation: Vaccine. 2008 Jan 10;26(2):193-200
references.pmid: 18054414
references.citation: Immunol Lett. 1990 Aug;25(1-3):243-9
references.pmid: 2283154
references.citation: JAMA. 2007 May 23;297(20):2220-6
references.pmid: 17519411
references.citation: Microbes Infect. 2006 Apr;8(5):1260-8
references.pmid: 16679042
references.citation: Lancet Infect Dis. 2012 Jun;12(6):457-68
references.pmid: 22445352
references.citation: Lancet. 1967 Jan 21;1(7482):138-40
references.pmid: 4163314
references.citation: Infect Immun. 2002 Dec;70(12):6948-60
references.pmid: 12438374
references.citation: Blood. 2012 Apr 19;119(16):3808-14
references.pmid: 22327223
references.citation: J Infect Dis. 2011 Dec 1;204(11):1750-61
references.pmid: 21998476
references.citation: PLoS One. 2012;7(10):e46424
references.pmid: 23071567
references.citation: J Infect Dis. 2004 Sep 1;190(5):1006-9
references.pmid: 15295709
references.citation: Acta Trop. 1997 Nov;68(2):175-82
references.pmid: 9386792
references.citation: PLoS Pathog. 2010 Feb 19;6(2):e1000770
references.pmid: 20174609
references.citation: Nature. 2005 Jun 23;435(7045):1117-21
references.pmid: 15973412
references.citation: Malar J. 2007 Jun 28;6:82
references.pmid: 17598897
references.citation: PLoS Med. 2010 Jan 19;7(1):e1000218
references.pmid: 20098724
references.citation: PLoS Med. 2005 May;2(5):e128
references.pmid: 15916466
references.citation: N Engl J Med. 2007 Nov 8;357(19):1903-15
references.pmid: 17989383
references.citation: Clin Vaccine Immunol. 2010 Oct;17(10):1552-9
references.pmid: 20702657
references.citation: Exp Parasitol. 2006 Feb;112(2):92-8
references.pmid: 16356497
references.citation: Infect Genet Evol. 2011 Aug;11(6):1287-92
references.pmid: 21549219
references.citation: Nature. 2001 Nov 15;414(6861):305-8
references.pmid: 11713529
references.citation: Clin Diagn Lab Immunol. 2004 Jan;11(1):6-11
references.pmid: 14715538
references.citation: Nature. 1961 Nov 25;192:733-7
references.pmid: 13880318
references.citation: Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):494-8
references.pmid: 1475814
references.citation: PLoS Med. 2007 Mar;4(3):e66
references.pmid: 17355169
references.citation: J Infect Dis. 2005 Jan 15;191(2):264-71
references.pmid: 15609237
references.citation: Infect Immun. 2010 Feb;78(2):737-45
references.pmid: 19917712
references.citation: Cell. 2011 Apr 29;145(3):398-409
references.pmid: 21529713
references.citation: J Infect Dis. 2008 Nov 1;198(9):1265-75
references.pmid: 18752444
references.citation: Int J Epidemiol. 1999 Aug;28(4):793-8
references.pmid: 10480713
references.citation: J Infect Dis. 2005 May 15;191(10):1623-30
references.pmid: 15838788